Latest News

The American drug regulator, the Food and Drug Administration (FDA), stated in a report yesterday that it may consider mandatory cardiovascular risk studies before considering any weight loss medication for approval, even if there is no evidence to suggest that there is any cardiovascular risk assoc...

The Food and Drug Administration (FDA) in the US has given the all clear for phase I trials of Antipotide(a potential new anti-obesity drug), having approved Arrowhead Research Corporation’s Investigational New Drug Application...

Topiramate has been proven to be a successful weight loss drug for those who can tolerate the side effects that go with it according to the results of a meta-analysis of previously published studies which will be presented at The Endocrine Society’s 93rd Annual Meeting in Boston...

The MHRA (Medicines and Healthcare products Regulatory Agency) will be issuing a new herbal regulation at the end of the month...

Vivus Inc has presented on the additional benefits of Qnexa at the American College of Cardiology suggesting that the pharmaceutical company might be closer than ever to gaining FDA (Food and Drug Administration) approval for its weight loss drug...